Molecule News and Research

RSS
New type of molecule shows early promise against treatment-resistant prostate cancer

New type of molecule shows early promise against treatment-resistant prostate cancer

Scientists develop new class of compounds for treatment of progressive neurodegenerative disorder

Scientists develop new class of compounds for treatment of progressive neurodegenerative disorder

Novartis: Lancet publishes pioneering study of Aimovig’s efficacy in episodic migraine patients

Novartis: Lancet publishes pioneering study of Aimovig’s efficacy in episodic migraine patients

AbbVie’s U-ACHIEVE Phase 2b/3 dose-ranging study improves outcomes in patients with ulcerative colitis

AbbVie’s U-ACHIEVE Phase 2b/3 dose-ranging study improves outcomes in patients with ulcerative colitis

Common antibodies associated with myocardial infarction

Common antibodies associated with myocardial infarction

SLU researcher seeks to find solutions for 'chemo brain' symptoms and side effects of opioids

SLU researcher seeks to find solutions for 'chemo brain' symptoms and side effects of opioids

New topical gel can prevent pesticide-induced toxicity and lethality

New topical gel can prevent pesticide-induced toxicity and lethality

New protein sequencing technique could revolutionize biomedical research

New protein sequencing technique could revolutionize biomedical research

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis

Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis

Deciphera presents Phase 1 clinical results of DCC-2618 in patients with gastrointestinal stromal tumors

Deciphera presents Phase 1 clinical results of DCC-2618 in patients with gastrointestinal stromal tumors

Gilead Sciences presents Phase 3 results of filgotinib in biologic-experienced rheumatoid arthritis at 2018 ACR/ARHP Annual Meeting

Gilead Sciences presents Phase 3 results of filgotinib in biologic-experienced rheumatoid arthritis at 2018 ACR/ARHP Annual Meeting

X4 Pharmaceuticals announces clinical data of X4P-001-IO and Opdivo in patients with clear cell renal cell carcinoma

X4 Pharmaceuticals announces clinical data of X4P-001-IO and Opdivo in patients with clear cell renal cell carcinoma

Understanding of metal-free enzymes used by bacteria could lead to new effective antibiotics

Understanding of metal-free enzymes used by bacteria could lead to new effective antibiotics

Newly developed synthetic DNA molecule may one day be used as 'vaccine' for prostate cancer

Newly developed synthetic DNA molecule may one day be used as 'vaccine' for prostate cancer

UT Southwestern biochemist receives 2019 Breakthrough Prize in Life Sciences for innate immunity discovery

UT Southwestern biochemist receives 2019 Breakthrough Prize in Life Sciences for innate immunity discovery

URMC researchers discover new approach to deliver therapeutics to the brain

URMC researchers discover new approach to deliver therapeutics to the brain

Scripps researchers successfully test potential new smoking-cessation treatment in rodents

Scripps researchers successfully test potential new smoking-cessation treatment in rodents

New urea sorbent could speed up the development of wearable artificial kidney

New urea sorbent could speed up the development of wearable artificial kidney

Molding bacteria into unnatural shapes reveals the robustness of cell division

Molding bacteria into unnatural shapes reveals the robustness of cell division